AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,917 | -12.6% | 1,532 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $43,386 | +23.5% | 1,532 | +0.1% | 0.00% | +33.3% |
| Q1 2023 | $35,144 | -18.3% | 1,530 | -0.1% | 0.00% | -25.0% |
| Q4 2022 | $43,019 | +0.0% | 1,532 | +0.1% | 0.00% | 0.0% |
| Q3 2022 | $43,000 | +26.5% | 1,530 | 0.0% | 0.00% | +33.3% |
| Q2 2022 | $34,000 | -24.4% | 1,530 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $45,000 | -10.0% | 1,530 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $50,000 | -29.6% | 1,530 | 0.0% | 0.00% | -40.0% |
| Q3 2021 | $71,000 | -15.5% | 1,530 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $84,000 | +6.3% | 1,530 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $79,000 | +19.7% | 1,530 | 0.0% | 0.01% | +20.0% |
| Q4 2020 | $66,000 | +112.9% | 1,530 | +73.9% | 0.01% | +66.7% |
| Q3 2020 | $31,000 | -34.0% | 880 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $47,000 | +51.6% | 880 | 0.0% | 0.00% | +33.3% |
| Q1 2020 | $31,000 | – | 880 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 3,057,869 | $86,477,000 | 2.23% |
| Eagle Health Investments LP | 329,713 | $9,324,000 | 2.14% |
| Bellevue Group AG | 4,058,792 | $114,783,000 | 1.65% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 959,214 | $27,127,000 | 1.13% |
| ARMISTICE CAPITAL, LLC | 1,924,000 | $54,411,000 | 0.94% |
| Integral Health Asset Management, LLC | 100,000 | $2,828,000 | 0.55% |
| Monarch Partners Asset Management LLC | 57,820 | $1,635,000 | 0.49% |
| ArrowMark Colorado Holdings LLC | 1,380,389 | $39,037,000 | 0.48% |
| AlphaCentric Advisors LLC | 15,000 | $424,000 | 0.44% |
| PDT Partners, LLC | 72,778 | $2,058,000 | 0.31% |